Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours Β· Estimated delivery Aug 25 - Aug 30
During your consultation, we provide a clear breakdown of all costs
Evidence grade: solid for topical skin benefit
Hematocrit and reticulocyte counts should be repeated daily from the fifth to seventh days of therapy and then frequently until the hematocrit is normal
Growth hormone therapy is a complex area of medicine
Practical Implications of No IGF-1 Elevation: The absence of IGF-1 stimulation makes AOD-9604 suitable for populations who need to avoid IGF-1 elevation, including individuals with personal or family history of hormone-sensitive cancers, those concerned about accelerated aging through growth pathway activation, people seeking fat loss without anabolic muscle-building effects, individuals who have contraindications to growth hormone therapy, and those undergoing screening or monitoring where IGF-1 elevation would be problematic
